BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, December 6, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 19, 2022
View Archived Issues
IKZF2 degrader PLX-4107 shows promise as cancer immunotherapeutic
Read More
New platform for rapid development of patient-specific APECs for ovarian carcinoma
Read More
Anti-CLDN18.2/CD47 antibody PT-886 shows antitumoral activity in model of pancreatic cancer
Read More
INBRX-130: a novel bispecific antibody targeting 5T4 and CD3
Read More
Shanghai Ringene Biopharma discovers S-adenosylmethionine synthase isoform type-2 inhibitors
Read More
New Bruton tyrosine kinase inhibitors synthesized at GenFleet Therapeutics
Read More
Medshine Discovery presents new PTPN11 inhibitors
Read More
New MAP4K1 inhibitors identified at Shenzhen Ionova Life Science
Read More
Shanghai Meiyue Biotech Development patents pantetheinase inhibitors
Read More
Cellectis details activity of allogeneic CAR-T cells targeting CD20 and CD22: UCART20x22
Read More
Microbe-sensing mechanism via neuronal Nod2 regulates appetite and metabolism
Read More
Biocytogen and CtM Biotech to develop novel immunotherapy candidates
Read More
Bridge Biotherapeutics inlicenses Shaperon's IPF candidate BBT-209
Read More
Targeting beta-catenin C-terminal domain/S1PR1 axis for vascular remodeling
Read More
CFT-1946 shows promising efficacy in BRAF-driven cancer models
Read More
ASC-11 demonstrates efficacy against different SARS-CoV-2 variants
Read More